Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know

Area of Science:

• Cardiology
• Medical Devices
• Interventional Procedures

Background:

• Non-valvular atrial fibrillation (AF) is a prevalent condition linked to a higher risk of thromboembolic events.
• Oral anticoagulant therapy (OAT) is standard for AF management but contraindicated in some patients due to bleeding risks.
• The left atrial appendage is a primary source of thrombi in AF, prompting alternative stroke prevention strategies.

Purpose of the Study:

• To review current understanding and clinical considerations for Left Atrial Appendage Occlusion (LAAO).
• To highlight LAAO as a non-pharmacological option for stroke risk reduction in specific AF patient populations.

Main Methods:

• This review synthesizes current literature and clinical perspectives on LAAO procedures.
• Focuses on LAAO as an alternative to OAT for patients with contraindications.

Main Results:

• Left atrial appendage occlusion (LAAO) is an emerging, effective alternative for cardioembolic event prevention.
• The demand for LAAO procedures is rapidly increasing, indicating growing clinical adoption.

Conclusions:

• LAAO is a viable, non-pharmacological strategy for patients with non-valvular AF and contraindications to OAT.
• Clinicians should consider LAAO when managing high-risk AF patients who cannot tolerate anticoagulation.